SpineGuard, a company listed on Euronext Growth, and specialized deploying its proprietary real time sensing technology DSG® (Dynamic Surgical Guidance) to streamline the placement of implants in the skeleton, announces a new equity financing.
This new financing aims at securing the Company’s cash runway in the context of both the COVID-19 pandemic and the Chapter 11 and French ‘sauvegarde’ plans currently being prepared.
This new financing amounting to 2.4 millions euros has been structured in the form of issuance of pre-paid warrants fully subscribed by Nice & Green, a company specialized in providing corporate services and flexible financing solutions to listed companies.
This issuance of pre-paid warrants in several tranches allows SpineGuard to receive 90% of the amount of each tranche at the subscription and to benefit upfront from almost of the amount of such tranches, the remaining amount being provided at the exercice of the warrants.
Nice & Green has been advised by Solferino Associés (Fouad Bellaaroussi).
SpineGuard has been advised by FLV Associés (Bastien Mathieu).
